Although rare, LRRK2 gene mutations have been termed a potential “Rosetta stone” of parkinsonian disorders as all of the major pathologies related to parkinsonism have been observed, in addition to there being end-stage variability, within families carrying the same pathogenic variant (Trinh et al., 2006). The gene discussed is LRRK2; the disease is Parkinson disease.